Pathos
PrivateLast Round
Series D
May 15, 2025
Est. Valuation
$1.6B
Total Funding Raised
$467M
Company Overview
Pathos is a biotechnology company that offers a drug discovery platform designed to expedite the medication development process through the use of big data, technology, and artificial intelligence for target identification and validation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pathos Comps
Public and private peers based on sector, stage, and business model.
Pathos Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | May 15, 2025 | ||||
| Series C | Oct 29, 2024 | ||||
| Series B | Mar 2, 2023 | ||||
| Series A | Jul 1, 2021 |
Key People
Founding team and executive leadership
Pathos Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Builders VC | Series C, Series B, Series A |
| Lightbank | Series C, Series B, Series A |
| New Enterprise Associates (NEA) | Series B, Series A, Series C |
| Revolution Ventures | Series C |
| Revolution Growth | Series C, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
AI drug development platform Foundry is now live and in production.
- Jan 10, 2026
Oncology drug programs in Phase 1/2 clinical trials with FDA IND applications.
Pathos Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pathos's valuation, stock price, and market status.
